• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novartis AG Common Stock (NY:NVS)

162.46 +1.21 (+0.75%)
Official Closing Price Updated: 7:00 PM EDT, Sep 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,344,102
Open 160.80
Bid (Size) 159.26 (100)
Ask (Size) 163.00 (300)
Prev. Close 161.25
Today's Range 160.38 - 163.18
52wk Range 121.57 - 170.46
Shares Outstanding N/A
Dividend Yield 2.94%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The Multiple Sclerosis Drug Race Just Got Hotter After Novartis’ Phase 3 Win ↗
September 01, 2026
Novartis stock spikes 5% on positive Phase 3 REMODEL trial results for relapsing MS drug remibrutinib with no liver safety signals. 
Via Benzinga
Tuesday's session: gap up and gap down stocks ↗
September 01, 2026
Via Chartmill

Performance

YTD
+17.3%
+17.3%
1 Month
+5.7%
+5.7%
3 Month
+13.1%
+13.1%
6 Month
-1.6%
-1.6%
1 Year
+28.3%
+28.3%

More News

Read More
News headline image
Why Novartis Just Surged 6%, Eyeing A Breakout ↗
September 01, 2026
Via Investor's Business Daily
News headline image
Hear from a prostate cancer patient about the one test more men should ask for
August 30, 2026
Via NewsUSA
Novartis (NYSE:NVS): A Dividend Quality Play for Income Investors ↗
August 21, 2026
Via Chartmill
Novartis (NYSE:NVS): A Top Dividend Stock with Strong Fundamentals and Sustainable Payouts ↗
July 29, 2026
Via Chartmill
News headline image
VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You? ↗
August 23, 2026
Via MarketBeat
Topics ETFs
News headline image
Breakfast News: A Conversation With Ionis CEO ↗
August 22, 2026
Via The Motley Fool
Topics ETFs World Trade
News headline image
Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI? ↗
August 18, 2026
Via The Motley Fool
Topics ETFs
News headline image
PPH vs. IYH: Which Healthcare Fund Is the Better Buy? ↗
August 18, 2026
Via The Motley Fool
Topics ETFs
News headline image
This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem ↗
August 17, 2026
Via MarketBeat
Topics Artificial Intelligence ETFs Stocks
News headline image
The L.A. Lakers Delivered a 1-Year Return of 25%. These ETFs Have Done Even Better. ↗
August 16, 2026
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
News headline image
Vanguard Is Bullish on Developed Markets Outside the U.S. -- But How Can You Buy Them? These 2 ETFs Can Help. ↗
August 14, 2026
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
News headline image
VanEck Pharmaceutical ETF vs. Invesco Biotech ETF: Which Fund Fits Your Investing Style? ↗
August 12, 2026
Via The Motley Fool
Topics ETFs
News headline image
3 Dividend Stocks to Buy for a Lifetime of Passive Income ↗
July 29, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Concentrated Pharma Exposure or Broader Global Healthcare? PPH vs. IXJ ↗
July 23, 2026
Via The Motley Fool
Topics ETFs
News headline image
Novartis (NVS) Q2 2026 Earnings Call Transcript ↗
July 21, 2026
Via The Motley Fool
Topics Earnings
News headline image
Novartis Q2 Earnings Call Highlights ↗
July 21, 2026
Via MarketBeat
Topics ETFs Earnings
News headline image
Novartis Q2 2026 Earnings Call Transcript ↗
July 21, 2026
Via Benzinga
Topics Earnings
News headline image
Novartis Bounds For Buy Point. Why Shares Are On The Rise. ↗
July 21, 2026
Via Investor's Business Daily
News headline image
Novartis Silences Generic Fears With Blowout Quarter, Packed Pipeline ↗
July 21, 2026
Via Benzinga
News headline image
For Global Pharma Exposure Is the VanEck Pharmaceutical ETF or iShares Healthcare Fund the Better Buy in 2026? ↗
July 20, 2026
Via The Motley Fool
Topics ETFs
News headline image
This Novartis Drug Could Help Delay Dialysis—FDA Grants Full Approval ↗
July 17, 2026
Via Benzinga
News headline image
StreetWatch: Nuvectis Pharma Eyes $9.8 Billion Oral PNH Market With Late-Stage NXP100 Backed by Strong Positive Phase 3 Data
July 14, 2026
Via Newsfile
News headline image
Global Nitrogen-Containing Bisphosphonate Drugs Market Growing at 3.1% CAGR Through 2032 ↗
July 14, 2026
Via Talk Markets

Frequently Asked Questions

Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 162.46
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 09/02/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap